tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

PCVX Stock Latest News

Vaxcyte vaccine candidates contain aluminum, says Mizuho
The FlyVaxcyte vaccine candidates contain aluminum, says Mizuho
14d ago
PCVX
Vaxcyte Holds Annual Stockholders Meeting on Governance
PremiumCompany Announcements
Vaxcyte Holds Annual Stockholders Meeting on Governance
16d ago
8K
PCVX
FDA head says vaccine framework being prepared
PremiumThe Fly
FDA head says vaccine framework being prepared
2M ago
GSK
PFE
Vaxcyte, Inc. Reports Q1 2025 Financial Results
PremiumCompany Announcements
Vaxcyte, Inc. Reports Q1 2025 Financial Results
2M ago
PCVX
Vaxcyte’s Long-Term Potential Overshadows Market Challenges: A Buy Recommendation
PremiumRatings
Vaxcyte’s Long-Term Potential Overshadows Market Challenges: A Buy Recommendation
2M ago
PCVX
Optimistic Outlook for Vaxcyte’s Vaccines Drives Buy Rating
PremiumRatingsOptimistic Outlook for Vaxcyte’s Vaccines Drives Buy Rating
2M ago
PCVX
Vaxcyte reports Q1 EPS ($1.04), consensus (98c)
Premium
The Fly
Vaxcyte reports Q1 EPS ($1.04), consensus (98c)
2M ago
PCVX
Vaxcyte Appoints Dr. Olivier Brandicourt to Board
Premium
Company Announcements
Vaxcyte Appoints Dr. Olivier Brandicourt to Board
2M ago
8K
PCVX
Vaxcyte appoints Brandicourt to board of directors
PremiumThe Fly
Vaxcyte appoints Brandicourt to board of directors
2M ago
SNY
PCVX
Vaxcyte initiated with an Overweight at Cantor Fitzgerald
PremiumThe Fly
Vaxcyte initiated with an Overweight at Cantor Fitzgerald
2M ago
PCVX
Vaxcyte initiated with an Overweight at Cantor Fitzgerald
PremiumThe Fly
Vaxcyte initiated with an Overweight at Cantor Fitzgerald
2M ago
PCVX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
PCVX
Vaxcyte’s Promising Prospects: Buy Rating Reinforced by Positive Phase 2 Data and Strategic Expansion
PremiumRatingsVaxcyte’s Promising Prospects: Buy Rating Reinforced by Positive Phase 2 Data and Strategic Expansion
3M ago
PCVX
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
CDT
HUT
Optimistic Buy Rating for Vaxcyte Amid Vaccine Development Challenges and Strategic Adjustments
Premium
Ratings
Optimistic Buy Rating for Vaxcyte Amid Vaccine Development Challenges and Strategic Adjustments
3M ago
PCVX
BofA lowers Vaxcyte price target, says selloff after infant data ‘overdone’
PremiumThe Fly
BofA lowers Vaxcyte price target, says selloff after infant data ‘overdone’
3M ago
PCVX
Vaxcyte’s Promising Vaccine Potential and Market Expansion Drive Buy Rating
PremiumRatings
Vaxcyte’s Promising Vaccine Potential and Market Expansion Drive Buy Rating
3M ago
PCVX
Vaxcyte’s Strong Phase 2 Data and Future Prospects Justify Buy Rating Despite Market Overreaction
PremiumRatings
Vaxcyte’s Strong Phase 2 Data and Future Prospects Justify Buy Rating Despite Market Overreaction
3M ago
PCVX
Vaxcyte price target lowered to $90 from $140 at Needham
PremiumThe Fly
Vaxcyte price target lowered to $90 from $140 at Needham
3M ago
PCVX
Vaxcyte’s VAX-24: Promising Infant Vaccine Results Amidst Investor Concerns
PremiumRatingsVaxcyte’s VAX-24: Promising Infant Vaccine Results Amidst Investor Concerns
3M ago
PCVX
Optimistic Outlook for Vaxcyte: Potential for Improved Vaccine Efficacy in Future Trials
Premium
Ratings
Optimistic Outlook for Vaxcyte: Potential for Improved Vaccine Efficacy in Future Trials
3M ago
PCVX
Vaxcyte ‘narrow’ misses in Phase 2 likely to be ok in Phase 3, says Evercore ISI
Premium
The Fly
Vaxcyte ‘narrow’ misses in Phase 2 likely to be ok in Phase 3, says Evercore ISI
3M ago
PCVX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >